Reiss-Clark Cindy 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Feb 20, 2025
Insider Transaction Report
Form 4
Reiss-Clark Cindy
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+246.162$51,940→ 5,130.508 total - Tax Payment
Common Stock
2025-02-18$211.00/sh−83.179$17,551→ 5,047.329 total - Award
Stock Option (Right to Buy)
2025-02-18+1,162→ 1,162 totalExercise: $211.00From: 2026-02-18Exp: 2035-02-18→ Common Stock (1,162 underlying) - Award
Rst. Stock Unit
2025-02-18+503→ 503 totalExercise: $0.00→ Common Stock (503 underlying)
Footnotes (1)
- [F1]This award vests in four equal installments beginning on February 18, 2026.